View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
MONDAY, April 9 (HealthDay News) -- Somatic mutations have been identified in two genes, FAT4 and ARID1A, involved in cell adhesion and chromatin remodeling in some patients with stomach cancer, according to a study published online April 8 in Nature Genetics.
To investigate the somatic alterations in gastric cancer, Zhi Jiang Zang, M.B.B.S., Ph.D., from the National Cancer Centre in Singapore, and colleagues sequenced the exomes of 15 gastric adenocarcinomas and their corresponding normal DNA.
The researchers identified 718 non-silent somatic point mutations in 661 genes. TP53, PIK3CA, and ARID1A were frequently mutated in adenocarcinomas (mutated in 11, three, and three adenocarcinoma exomes, respectively). The biological pathway most enriched among the frequently mutated genes was cell adhesion. In a cadherin family gene, FAT4, prevalence screening confirmed mutations in 5 percent and genomic deletions in 4 percent of gastric tumors. In 47 percent of gastric cancers, frequent mutations were seen in chromatin remodeling genes (MLL3, MLL, and ARID1A). ARID1A mutations were detected in 8 percent of tumors, and were linked with concomitant PIK3CA mutations and microsatellite instability. Both FAT4 and ARID1A were found to exert tumor-suppressor activity in functional assays.
"Somatic inactivation of FAT4 and ARID1A may thus be key tumorigenic events in a subset of gastric cancers," Zang and colleagues conclude.
Full Text (subscription or payment may be required)
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top